How often have you opened your medicine cabinet and wondered: Can I still trust this drug? Is it working as it should?
For many, the answer is a matter of cost to replace it. For those with chronic diseases, it can be way more complicated and life-threatening.
Because millions of people worldwide use medicines daily without knowing if they remain effective, as heat, transport, storage, and handling silently degrade potency - yet no one measures drug activity at the point of use.
At Beyond Diagnostics, we are the first to tackle this blind spot. We develop real-time point-of-care tests that verify whether medications still work. Starting with insulin, our LUMIQ platform will safeguard fragile biologics and introduce a new layer of trust in global healthcare.
No news
11.02.2026
ATTD Ignite Winner
01.02.2026
First functional prototype for insulin activity testing developed
01.08.2025
Stage Up Award Winner
01.12.2024
Selected as Top 5 Digital Health Nation Switzerland
01.12.2024
Innosuisse Innovation Grant
No Jobs
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
Website:
www.beyond-diagnostics.com
Headquarter:
Bern
Foundation Date:
February 2026
Technology:
Sectors: